European ScreeningPort GmbH

European ScreeningPort GmbH is a company in Hamburg, Germany that has taken part in 10 EU-funded projects since 2011, receiving €2.2M in EU funding.

EU funding received€2.2M
EU projects10
As coordinator0
Running now0
First EU project2011
Latest project2014
CountryGermany
EU registration (PIC)989812736
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are European ScreeningPort GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.2M · 10 projects

Projects

10 EU-funded projects, newest first. Each links to the official record.

  • PDE4NPDPartner

    Parasite-specific cyclic nucleotide phosphodiesterase inhibitors to target Neglected Parasitic Diseases

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €32ktheir share
  • DROPTECHPartner

    Hanging Drop based automated and parallelized cell technology platform for production and testing

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €943ktheir share
  • NMTRYPIPartner

    New Medicines for Trypanosomatidic Infections

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €87ktheir share
  • EBISCPartner

    European Bank for induced pluripotent Stem Cells

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €15ktheir share
  • CVGENES-AT-TARGETPartner

    Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €61ktheir share
  • TRANSLOCATIONPartner

    MOLECULAR BASIS OF ANTIBIOTIC TRANSLOCATION

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  • TRANSLOCATIONPartner

    Molecular basis of the outer membrane permeability

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €233ktheir share
  • K4DDPartner

    Kinetics for Drug Discovery (K4DD)

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €141ktheir share
  • EURHYTHDIAPartner

    Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €375ktheir share
  • MARINE FUNGIPartner

    Natural products from marine fungi for the treatment of cancer

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €323ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotics
  • arteriosclerosis
  • bacteriology
  • diabetes
  • drug discovery
  • drug resistance
  • energy and fuels
  • infectious diseases
  • law
  • lipids
  • malaria
  • microfluidics
  • multidrug resistance
  • mycology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime